Literature DB >> 26840963

Does Alkaline Colonic pH Predispose to Clostridium difficile Infection?

Purba Gupta1, Stanley Yakubov1, Kevin Tin1, Diego Zea1, Olga Garankina1, Monica Ghitan1, Edward K Chapnick1, Peter Homel1, Yu Shia Lin1, Michael M Koegel1.   

Abstract

OBJECTIVES: Clostridium difficile caused nearly 500,000 infections and was associated with approximately 29,000 deaths in 2011, according to data from the Centers for Disease Control and Prevention. C. difficile is a bacterium that causes diarrhea and, often, severe illness in healthcare facilities, as well as the community. Our objective was to determine whether alkaline colonic pH predisposes to colonization and infection with C. difficile.
METHODS: A total of 228 patients with diarrhea and/or abdominal pain, leukocytosis, and fever were included. Stool pH was measured, and C. difficile antigen and toxin in stool were detected.
RESULTS: Of 228 patients, 30 (13.2%) tested positive for C. difficile (antigen+/toxin+) and 171 (75%) were C. difficile negative (antigen-/toxin-). Of 171 patients who tested negative, 93 (54.4%) had stool pH >7.0 and 78 (45.6%) had pH ≤7.0. Among the 30 patients who tested positive, 26 (86.7%) had stool pH >7.0 (P = 0.002). Among the 27 colonized patients (antigen+/toxin-), 12 (44.4%) had stool pH >7.0 (P = 0.34). For all patients with stool pH ≤7.0, 96% tested negative for C. difficile infection (P = 0.002).
CONCLUSIONS: A strong association between C. difficile infection and alkaline stool pH was found.

Entities:  

Mesh:

Year:  2016        PMID: 26840963     DOI: 10.14423/SMJ.0000000000000414

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Authors:  Daniela Wetzel; Shonna M McBride
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

Review 2.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 3.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

4.  S-Nitrosoglutathione formation at gastric pH is augmented by ascorbic acid and by the antioxidant vitamin complex, Resiston.

Authors:  Vitali I Stsiapura; Ilya Bederman; Ivan I Stepuro; Tatiana S Morozkina; Stephen J Lewis; Laura Smith; Benjamin Gaston; Nadzeya Marozkina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

Review 5.  Clostridium difficile and Antibiotic-associated Diarrhea.

Authors:  Mahuya Bhattacharyya; Anindya Kishore Debnath; Subhash K Todi
Journal:  Indian J Crit Care Med       Date:  2020-09

Review 6.  The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection.

Authors:  Dania Tawam; Michael Baladi; Paiboon Jungsuwadee; Grace Earl; Jayoung Han
Journal:  Innov Pharm       Date:  2021-03-09

7.  Analysis of Perioperative Risk Factors for Clostridium difficile Infection After a Colectomy.

Authors:  Karen Kong; Sara S Soliman; Rolando H Rolandelli; Matthew J Elander; Joseph Flanagan; Daniel Hakakian; Zoltan H Nemeth
Journal:  Cureus       Date:  2021-12-03

Review 8.  Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults.

Authors:  Iulia-Magdalena Vasilescu; Mariana-Carmen Chifiriuc; Gratiela Gradisteanu Pircalabioru; Roxana Filip; Alexandra Bolocan; Veronica Lazăr; Lia-Mara Diţu; Coralia Bleotu
Journal:  Front Microbiol       Date:  2022-01-20       Impact factor: 5.640

9.  Negative interactions determine Clostridioides difficile growth in synthetic human gut communities.

Authors:  Susan Hromada; Yili Qian; Tyler B Jacobson; Ryan L Clark; Lauren Watson; Nasia Safdar; Daniel Amador-Noguez; Ophelia S Venturelli
Journal:  Mol Syst Biol       Date:  2021-10       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.